Sign in
Companies / VTRS vs ZTS

VTRS vs ZTS: Viatris and Zoetis

Pharmaceuticals
Compare more companies

Viatris (VTRS) reported $14.3B in revenue against a -24.6% net margin, while Zoetis (ZTS) reported $9.5B at a 28.2% net margin, most recently.

MetricVTRSZTS
Revenue$14.3B$9.5B
Net Income$-3.5B$2.7B
Gross Margin35.1%71.8%
Operating Margin-18.6%—
EPS (Diluted)$-3.00$6.02
Free Cash Flow$1.9B$2.3B
Total Debt$14.4B$9.0B
P/E Ration/m20.9×
P/B Ration/m16.1×
Stock Price$19.00$82.13
Free: last 5 years
Fiscal yearFY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
VTRS Revenue•••••••••••••••$17.9B$16.3B$15.4B$14.7B$14.3B
ZTS Revenue•••••••••••••••$7.8B$8.1B$8.5B$9.3B$9.5B

More on VTRS

More on ZTS

Other comparisons